The molecular basis of breast cancer pathological phenotypes
Yujing J. Heng(Beth Israel Deaconess Medical Center), Andrew H. Beck(Brown University), Rahi Punjabi(Beth Israel Deaconess Medical Center), David A. Eberhard, Benjamin Haibe‐Kains(University of Toronto), Frederic M. Waldman(University of California, San Francisco), Susan C. Lester(University of Vermont), Rachel E. Factor(Brigham and Women's Hospital), Melinda E. Sanders(Vanderbilt University), Jong Cheol Jeong(University of Kentucky), Laura C. Collins(Beth Israel Deaconess Medical Center), Kamaljeet Singh, Kristin C. Jensen(Shaanxi Research Association for Women and Family), Deena M.A. Gendoo(University of Birmingham), Sydney R Flanagan(Beth Israel Deaconess Medical Center), Yunn‐Yi Chen(University of Vermont), Giovanni Ciriello(SIB Swiss Institute of Bioinformatics), Charles M. Perou(University of North Carolina at Chapel Hill), Gary M. Tse(Second Hospital of Tianjin Medical University), David A. Gutman(Emory University), Puay Hoon Tan(Eye & Retina Surgeons), Jorge S. Reis‐Filho(AstraZeneca (France)), Kimberly H. Allison(Stanford University), Gregor Krings(Cleveland Clinic), Nicole B. Johnson(Beth Israel Deaconess Medical Center), Sandra J. Shin(Cornell University), Gregory M. Chen(University of Pennsylvania), Konstanty Korski(Greater Poland Cancer Center), Katherine A. Hoadley(University of North Carolina at Chapel Hill)
Cited by 114
Related Papers
Comprehensive molecular characterization of gastric adenocarcinoma
|Nature|2014|6.6k
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k